Added to YB: 2024-01-02
Pitch date: 2024-01-02
INSM [bullish]
Insmed Incorporated
+571.24%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
Market Cap
$42.0B
Pitch Price
$29.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
-43.68
P/E
-31.68
EV/Sales
91.89
Sector
Biotechnology
Category
growth
Show full summary:
$INSM - I like Brenso readout chances in Q2
$INSM: Bullish on Brenso Q2 readout - huge revenue potential w/ no competition & high barriers. Positive readout could mirror VRTX/ARGX. TPIP misunderstood & has value; April P2 data.
Read full article (1 min)